ConjuChem is Biotechnology in Canada that focus on ConjuChem Biotechnologies Inc business. Founded in 1997. They cover business area such as ConjuChem Biotechnologies Inc, novel, next-generation medicine, long-act therapeutic peptide, -conjugation platform, Drug Affinity Complex, (DAC, Preformed, (pc-DAC, a give peptide, PC- DAC, new drug, similar therapeutic activity, long duration, improve safety profile, diabetes, pc-DAC Insulin, DAC HIV.
1997
( 27 years old in 2024 )
ConjuChem Biotechnologies Inc
-
225 President-Kennedy Avenue
Suite 3950
Montreal, Quebec H2X 3Y8
Canada
Private
ConjuChem Biotechnologies Incnovelnext-generation medicinelong-act therapeutic peptide-conjugation platformDrug Affinity Complex(DACPreformed(pc-DACa give peptidePC- DACnew drugsimilar therapeutic activitylong durationimprove safety profilediabetespc-DAC InsulinDAC HIV
* We use standard office opening hours in near ConjuChem's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ConjuChem is Biotechnology business from Canada that founded in 1997 (27 years old in 2024), ConjuChem business is focusing on ConjuChem Biotechnologies Inc.
ConjuChem headquarter office and corporate office address is located in 225 President-Kennedy Avenue Suite 3950 Montreal, Quebec H2X 3Y8 Canada.
ConjuChem was founded in Canada.
In 2024, ConjuChem is currently focus on ConjuChem Biotechnologies Inc sector.
Above is snippet of Google Trends for "ConjuChem Biotechnologies Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ConjuChem, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
